Notification of decision to issue a licence on application - posted 5 October 2012
PDF 62 KB
HTML
Questions and Answers
PDF 9 KB
HTML
Risk Assessment and Risk Management Plan (RARMP) Executive Summary
PDF 59 KB
HTML
Risk Assessment and Risk Management Plan (RARMP) Technical Summary
PDF 85 KB
HTML
Full Risk Assessment and Risk Management Plan (RARMP) for the limited and controlled release of genetically modified live viral vaccines against prostate cancer
PDF 538 KB
HTML
Licence Application Summary
PDF 170 KB
HTML
GM Viral Vaccine Licence Conditions
PDF 350 KB
HTML